Three months after Bristol Myers Squibb revealed the success of two phase 3 trials of its oral targeted therapy Sotyktu in ...

The TYK2 inhibitor deucravacitinib (Sotyktu) showed clinical potential in two diseases other than psoriasis, according to ...

Nummular dermatitis, also called nummular eczema and discoid eczema, causes itchy ... Because of its round appearance, it can be mistaken for ringworm or psoriasis. While the cause of nummular ...

Mar. 3, 2025 — Psoriasis is one of the most common chronic inflammatory skin diseases, affecting around 250,000 people in Austria. While previous treatment approaches have mainly focused on ...

Some evidence suggests a higher risk of liver disease with psoriasis. Certain psoriasis treatments can cause liver toxicity, but the two conditions also share common risk factors, which may ...

Doctors advise you to approach HRT with caution if you have lupus. HRT may increase the risk of flares or blood clots in some people. There are factors that you need to consider if you have lupus ...

Johnson & Johnson has moved a step closer to filing a potential first-in-class therapy for psoriasis after the drug hit the mark in a phase 3 trial. Once-daily oral IL-23 inhibitor icotrokinra ...

12 According to the National Eczema Society, children of color are more likely to develop discoid eczema (circumscribed patches of eczema) than White children. Regardless of skin color ...